Labeler
Alvogen Inc. NDC Codes
Alvogen Inc. lists 80 finished drug products in the FDA NDC Directory under NDC labeler code 47781.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- levothyroxine sodium, Hydrocodone Bitartrate, lisdexamfetamine dimesylate, Lenalidomide, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII, buprenorphine transdermal system, Buprenorphine and Naloxone Sublingual Film, Oseltamivir Phosphate, Oxycodone and Acetaminophen, Oxycodone hydrochloride, sertraline hydrochloride, testosterone cypionate, Dexamethasone, Rasagiline, Naproxen Sodium
- Active ingredients
- Levothyroxine sodium, Hydrocodone bitartrate, Lisdexamfetamine dimesylate, Lenalidomide, Oxycodone hydrochloride, Amphetamine aspartate monohydrate, Amphetamine sulfate, Dextroamphetamine saccharate, Dextroamphetamine sulfate, Buprenorphine, Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate
- NDC labeler codes
- 47781
- Strengths
- Acetaminophen 325 mg/1; Teriparatide 250 ug/mL; Testosterone cypionate 200 mg/mL; Hydrocodone bitartrate 20 mg/1; Hydrocodone bitartrate 30 mg/1; Hydrocodone bitartrate 40 mg/1; Levothyroxine sodium 112 ug/1; Levothyroxine sodium 175 ug/1; Oxycodone hydrochloride 5 mg/1; Sertraline hydrochloride 150 mg/1; Sertraline hydrochloride 200 mg/1; Lisdexamfetamine dimesylate 10 mg/1; Lisdexamfetamine dimesylate 20 mg/1; Lisdexamfetamine dimesylate 30 mg/1; Lisdexamfetamine dimesylate 40 mg/1; Lisdexamfetamine dimesylate 50 mg/1; Lisdexamfetamine dimesylate 60 mg/1; Lisdexamfetamine dimesylate 70 mg/1; Lenalidomide 2.5 mg/1; Lenalidomide 20 mg/1
- Dosage forms
- Tablet, Capsule, Tablet, Extended release, Capsule, Extended release, Injection, Solution, Patch, Extended release, Film, Tablet, Film coated, Extended release, Cream, Powder, For suspension
- Routes
- Oral, Transdermal, Buccal, Sublingual, Subcutaneous, Intramuscular, Vaginal
- Drug classes (FDA established)
- Central Nervous System Stimulant, Opioid Agonist, l-Thyroxine, Partial Opioid Agonist, Thalidomide Analog, Opioid Antagonist, Neuraminidase Inhibitor, Serotonin Reuptake Inhibitor, Parathyroid Hormone Analog, Androgen, Corticosteroid, Monoamine Oxidase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Nitrofuran Antibacterial, Estrogen, Cholinesterase Inhibitor, Aldehyde Dehydrogenase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 107
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| sertraline hydrochloride | Sertraline hydrochloride 150 mg/1 | CapsuleOral | 47781-951 | 47781-0951-30 | — |
| sertraline hydrochloride | Sertraline hydrochloride 200 mg/1 | CapsuleOral | 47781-962 | 47781-0962-30 | — |
| Bonsityteriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | 47781-852 | 47781-0852-89 | — |
| lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | CapsuleOral | 47781-562 | 47781-0562-01 | — |
| lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | CapsuleOral | 47781-563 | 47781-0563-01 | — |
| lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | CapsuleOral | 47781-564 | 47781-0564-01 | — |
| lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | CapsuleOral | 47781-565 | 47781-0565-01 | — |
| lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 50 mg/1 | CapsuleOral | 47781-566 | 47781-0566-01 | — |
| lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | 47781-567 | 47781-0567-01 | — |
| lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | 47781-568 | 47781-0568-01 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 47781-483 | 47781-0483-0147781-0483-28 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 47781-487 | 47781-0487-0147781-0487-77 | — |
| testosterone cypionate | Testosterone cypionate 200 mg/mL | Injection, SolutionIntramuscular | 47781-910 | 47781-0910-91 | — |
| testosterone cypionate | Testosterone cypionate 200 mg/mL | Injection, SolutionIntramuscular | 47781-911 | 47781-0911-93 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 47781-484 | 47781-0484-0147781-0484-28 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 47781-485 | 47781-0485-0147781-0485-28 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 47781-486 | 47781-0486-0147781-0486-77 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 47781-488 | 47781-0488-0147781-0488-77 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 5 ug/h | Patch, Extended releaseTransdermal | 47781-406 | 47781-0406-04 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 10 ug/h | Patch, Extended releaseTransdermal | 47781-407 | 47781-0407-04 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 20 ug/h | Patch, Extended releaseTransdermal | 47781-408 | 47781-0408-04 | — |
| buprenorphine transdermal systembuprenorphine | Buprenorphine 15 ug/h | Patch, Extended releaseTransdermal | 47781-419 | 47781-0419-04 | — |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | 47781-914 | 47781-0914-0147781-0914-51 | — |
| Dexamethasone | Dexamethasone 6 mg/1 | TabletOral | 47781-916 | 47781-0916-01 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 20 mg/1 | Tablet, Extended releaseOral | 47781-392 | 47781-0392-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 30 mg/1 | Tablet, Extended releaseOral | 47781-393 | 47781-0393-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 40 mg/1 | Tablet, Extended releaseOral | 47781-394 | 47781-0394-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 60 mg/1 | Tablet, Extended releaseOral | 47781-395 | 47781-0395-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 80 mg/1 | Tablet, Extended releaseOral | 47781-396 | 47781-0396-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 100 mg/1 | Tablet, Extended releaseOral | 47781-397 | 47781-0397-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 120 mg/1 | Tablet, Extended releaseOral | 47781-398 | 47781-0398-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 10 mg/1 | Capsule, Extended releaseOral | 47781-409 | 47781-0409-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 15 mg/1 | Capsule, Extended releaseOral | 47781-410 | 47781-0410-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 20 mg/1 | Capsule, Extended releaseOral | 47781-411 | 47781-0411-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 30 mg/1 | Capsule, Extended releaseOral | 47781-412 | 47781-0412-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 40 mg/1 | Capsule, Extended releaseOral | 47781-413 | 47781-0413-60 | — |
| Hydrocodone Bitartrate | Hydrocodone bitartrate 50 mg/1 | Capsule, Extended releaseOral | 47781-414 | 47781-0414-60 | — |
| teriparatide | Teriparatide 250 ug/mL | Injection, SolutionSubcutaneous | 47781-652 | 47781-0652-89 | — |
| levothyroxine sodium | Levothyroxine sodium 25 ug/1 | TabletOral | 47781-640 | 47781-0640-1047781-0640-90 | — |
| levothyroxine sodium | Levothyroxine sodium 50 ug/1 | TabletOral | 47781-643 | 47781-0643-1047781-0643-90 | — |
| levothyroxine sodium | Levothyroxine sodium 75 ug/1 | TabletOral | 47781-646 | 47781-0646-1047781-0646-90 | — |
| levothyroxine sodium | Levothyroxine sodium 88 ug/1 | TabletOral | 47781-649 | 47781-0649-1047781-0649-90 | — |
| levothyroxine sodium | Levothyroxine sodium 100 ug/1 | TabletOral | 47781-651 | 47781-0651-1047781-0651-90 | — |
| levothyroxine sodium | Levothyroxine sodium 112 ug/1 | TabletOral | 47781-654 | 47781-0654-1047781-0654-90 | — |
| levothyroxine sodium | Levothyroxine sodium 125 ug/1 | TabletOral | 47781-657 | 47781-0657-1047781-0657-90 | — |
| levothyroxine sodium | Levothyroxine sodium 137 ug/1 | TabletOral | 47781-659 | 47781-0659-1047781-0659-90 | — |
| levothyroxine sodium | Levothyroxine sodium 150 ug/1 | TabletOral | 47781-662 | 47781-0662-1047781-0662-90 | — |
| levothyroxine sodium | Levothyroxine sodium 175 ug/1 | TabletOral | 47781-665 | 47781-0665-1047781-0665-90 | — |
| levothyroxine sodium | Levothyroxine sodium 200 ug/1 | TabletOral | 47781-668 | 47781-0668-1047781-0668-90 | — |
| levothyroxine sodium | Levothyroxine sodium 300 ug/1 | TabletOral | 47781-671 | 47781-0671-1047781-0671-90 | — |
Alvogen Inc.: common questions
- What is Alvogen Inc.'s NDC labeler code?
- 47781. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Alvogen Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.